Skip to contentS
Surgery Partners, Inc.
S
SGRYSurgery Partners, Inc. Q1 2025 · 10-Q
Revenue$776.00M$776.00M+8.2% vs Q1 2024 Net Income-$37.70M-$37.70MN/M vs Q1 2024 EPS Diluted-$0.30-$0.30N/M vs Q1 2024 Operating Income$61,900,000−18.6% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Surgery Partners, Inc. · CIK 1638833 · Engraved from SEC EDGAR
Free Cash Flowderived-$16,700,000N/M Margins · derivedOperating margin8.0%−2.6 pt vs Q1 2024
Net margin-4.9%−3.1 pt vs Q1 2024
ended Mar 31, 2025 · filed May 12, 2025 · 42 d after period end